3D Cell Culture Industry

The global 3D cell culture market was valued at USD 1.57 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 11.22% from 2024 to 2030. This growth is primarily driven by rising efforts to develop alternatives to animal-based testing, supported by increasing availability of funding programs for research. Furthermore, the biopharmaceutical industry’s continued emphasis on research and development (R&D) activities for drug discovery and development, along with the growing adoption of 3D cell cultures in cancer research, are expected to contribute significantly to market expansion. Traditionally, animal models have been widely used in cellular-based studies for understanding disease mechanisms; however, these models have limitations, such as differences in species-specific responses and lack of accurate outcomes. To address these challenges, various government organizations are promoting alternative methods for drug development, enhancing the appeal of 3D cell cultures.

The COVID-19 pandemic has had a considerable impact on the 3D cell culture market. The outbreak offered researchers the chance to study the novel virus and develop therapeutic and diagnostic solutions. Many leading pharmaceutical and biotechnology companies have increased their R&D efforts to create innovative vaccines, therapies, and diagnostic kits, thereby driving up demand for cell culture tools. The pandemic also heightened the need for new cell-based models, organoids, and high-throughput screening platforms to support research and drug discovery initiatives. Additionally, the urgency to develop vaccines and treatments for COVID-19 led to a surge in demand for bioreactors and culture systems, which are critical in vaccine production and drug testing. Consequently, the pandemic not only accelerated innovation in the 3D cell culture market but also underscored the importance of advanced cell culture technologies in addressing global health challenges.

Gather more insights about the market drivers, restrains and growth of the 3D Cell Culture Market

Technology Insights

Scaffold-Based Segment Dominance (48.94% Market Share in 2023):

• The scaffold-based segment held the largest market share of 48.94% in 2023.
• This segment is further subdivided into various types of scaffolds, including:
• Hydrogels
• Polymeric scaffolds
• Micropatterned surface microplates
• Nanofiber-based scaffolds

Factors Driving Scaffold-Based Segment Growth:

• Increasing applications of scaffold-based cultures in tissue engineering and regenerative medicine are expected to propel segment growth.
• Advancements in scaffold materials and fabrication techniques are enhancing the effectiveness of these scaffolds in research and therapeutic applications.
• Growing research funding and collaboration initiatives are further supporting the development and adoption of scaffold-based technologies.

Hydrogels in 3D Cell Culture:

• Hydrogels are widely used as scaffolds in 3D cell culture model studies, allowing for the incorporation of biochemical and mechanical signals that closely mimic the native extracellular matrix.

Technological Advancements and Product Launches:

• Recent technological advancements and ongoing research activities are projected to fuel growth in the scaffold-based segment.
• For example, in June 2022, Dolomite Bio launched novel hydrogel-focused reagent kits designed for high-throughput encapsulation of cells within hydrogel scaffolds.
• Additionally, ongoing research efforts to develop innovative scaffold-based technologies contribute to market expansion. Notably, in May 2023, researchers from the National University of Singapore (NUS) successfully utilized common plant proteins to 3D print an edible cell culture scaffold.

Scaffold-Free Segment Growth:

• The scaffold-free segment is expected to register the fastest compound annual growth rate (CAGR) over the forecast period.
• Key factors contributing to this rapid growth include:
• Enhanced cellular interactions
• Higher throughput and scalability of scaffold-free systems
• Rising demand for personalized medicine, which emphasizes tailored therapeutic approaches
• Advancements in 3D culture model platforms and technologies

Robust Demand for Scaffold-Free Systems:

• There is a strong demand for scaffold-free systems across various end users, including:
• The biopharmaceutical industry
• Research institutes
• This growing demand is further driving the expansion of the scaffold-free segment within the 3D cell culture market.

Order a free sample PDF of the 3D Cell Culture Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com/

Follow Us: LinkedIn | Twitter